Velcura Therapeutics met with FDA to clarify details for the early clinical development of VEL-0230, a drug developed to treat bone disease.
Ads by Google
Drug Clinical Trials
Eli Lilly and Company announced study results comparing treatment of exenatide injection with insulin glargine on beta-cell function, glycemic control and weight in people with type 2 diabetes.
EpiStem has completed the first year of mucositis efficacy-testing services for potential biodefense drugs.
In study comparing risedronate 150 mg once monthly to risedronate 5 mg daily increases in bone mineral density were similar for patients taking either the monthly or daily dosing regimens.
Terumo Heart announced successful results from DuraHeart LVAS clinical trial.
Phosphagenics Limited plans to undertake a Phase 1 transdermal oxycodone clinical trial aimed at providing chronic pain sufferers with a sustained-release pain management product.
Boehringer Ingelheim will publish results from the RE-NOVATE study, which investigated dabigatran etexilate as a potential therapy for patients undergoing total hip replacement surgery.
MIGENIX will present results of viral resistance studies with its anti-HCV agent celgosivir at the 14th International Symposium on Hepatitis C Virus and Related Viruses.
As the United States considers allowing experimental drugs to be given to people at the end of life, two experts in this week's BMJ debate whether terminally ill patients should have the right to take drugs after initial safety (phase I) trials but before final approval.
Tourtellotte Solutions released tcVisualize 3.0 clinical trial supply simulator.
Opko Health announced first patient enrollment in the Phase 3 COBALT clinical trial of bevasiranib for the treatment of wet age-related macular degeneration.
Pharmaxis announced that Phase III B301 study of Bronchitol for the treatment of people with bronchiectasis has met its two primary efficacy endpoints: quality of life and mucus clearance.
Neurochem announces top-line results from the North American Phase III clinical trial designed to assess the safety, efficacy and disease modification effect of tramiprosate (ALZHEMED) for the treatment of Alzheimer's disease.
Finding ways to effectively treat bacterial infections with antibiotics that minimize the development of drug resistance is a key goal of antimicrobial resistance research.
Terminally ill patients do not have the right to obtain access to unapproved prescription drugs that potentially are lifesaving.
Pharmacists filed a lawsuit claiming that a Washington Board of Pharmacy rule violates their civil rights.
WHO announces the expansion of its clinical trial registry platform to include trial registers from China and India.
Arena Pharmaceuticals initiated dosing in a Phase 1 clinical trial evaluating APD791, Arena's drug candidate intended for the treatment of arterial thrombo-embolic diseases.
Avicena Group and FDA will proceed with a confirmatory Phase III trial for treatment of amyotrophic lateral sclerosis.
Protalix BioTherapeutics has reached an agreement with FDA on the final design of its pivotal phase III clinical trial.
Cytel released East 5, a major advancement to Cytel's highly-validated clinical trial design and monitoring software system.
A two-week clinical trial to test the microbicide VivaGel.
Vical Incorporated announced the enrollment of hematopoietic stem cell transplant recipient in Phase 2 trial of a DNA vaccine against cytomegalovirus.
Portola Pharmaceuticals announced positive Phase II data on its lead compound, PRT054021, an oral Factor Xa inhibitor.
Enhanze Technology clinical trial demonstrated improved absorption and bioavailability of a representative commercially-available large protein molecule therapeutic.
Clinical studies to assess the safety and efficacy of tolevamer liquid, an investigational, non-antibiotic, polymer therapy for patients with Clostridium difficile associated diarrhea.
Phase 3 study showed that 77 percent of treatment-experienced HIV-1 infected adults taking PREZISTA reached a plasma viral load of 400 copies/mL.